Relacorilant induces lower ACTH and cortisol increases in ACTH-dependent CS compared to mifepristone, thus preventing 11βHSD2 saturation and typical side effects of mineralocorticoid excess. Here, POMC is linked to Increased circulating aldosterone concentration.